Applications of N-Boc-D-Phenylalaninol in Industrial Manufacturing

N-Boc-D-Phenylalaninol serves as a key chiral intermediate across several advanced industrial sectors, supporting the synthesis of complex molecules within regulated production environments. Drawing on extensive manufacturer expertise, we provide consistent quality material for established downstream fields, ensuring traceable integration and batch control from the raw ingredient to finished formulations. The application scenarios below outline common usage parameters and technical requirements across major sectors.

1. Chiral Building Block in Pharmaceutical API Synthesis

Pharmaceutical API plants incorporate this compound as a stereocontrolled building block during the asymmetric synthesis of new generation beta-lactam antibiotics, D-type chiral intermediates, and peptidomimetic drugs. Its use centers around enhancing yield of target enantiomers, supporting validated batch records under GMP oversight. As a protected amino alcohol, it is positioned at a key step within multi-stage formulation, where precise input weight and purity sustain reproducible downstream coupling or cyclization reactions.

Industry compliance standards

• Good Manufacturing Practice (GMP, ICH Q7)
• Current United States Pharmacopeia (USP)
• European Pharmacopoeia (EP) for intermediate handling
• FDA 21 CFR Part 211 – Finished Pharmaceuticals

Typical usage ratio

• 10–35 mol% relative to API target batch size; adjusted to reaction design and selectivity requirements

Downstream process integration

• Fed into protected amino alcohol coupling following Boc deprotection
• Used for enantioselective alkylation or cyclization steps in multi-stage synthesis
• Reacts in controlled temperature solvent systems (e.g., DMF, DCM)
• Integrated with in-process chiral analysis (HPLC, GC)

Final product types

• Active Pharmaceutical Ingredients (APIs) containing D-phenylalanine moieties
• Beta-lactam antibiotics (e.g., advanced cephalosporin intermediates)
• Chiral peptidomimetics and non-proteinogenic peptides
• Chemical reference standards for analytical labs

2. Advanced Intermediate in Peptide Synthesis

Custom peptide manufacturers employ this protected amino alcohol to introduce D-configured phenylalanine analogs into specialty peptides, supporting sequences with enhanced metabolic stability or therapeutic activity. Ingredient selection follows automated solid-phase or liquid-phase peptide assembly paths, where control over loading and deprotection influences sequence accuracy and chiral purity in the resulting oligopeptides or cyclic peptides.

Industry compliance standards

• ISO 9001:2015 Quality Management System
• Peptide Synthesis for Pharmaceutical Use – EMA Guidelines
• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals)
• Synthetic Peptide APIs: ICH Q11

Typical usage ratio

• 10–18 mol% per equivalent D-phenylalanine residue within designed peptide batch

Downstream process integration

• Incorporated into Fmoc/Boc-based automated peptide synthesizers post-deprotection
• Used in cyclization or side-chain modification steps of semi-synthetic peptides
• Checked for integrity by HPLC and LC-MS during product release
• Final Boc removal after peptide chain extension

Final product types

• Custom therapeutic peptides with D-phenylalaninol segments
• Peptide substrates for protease research
• Diagnostic peptide kits
• Peptidomimetic drug candidates

3. Chiral Ligand Precursor in Asymmetric Catalysis

Producers of chiral catalysts and ligands utilize N-Boc-D-Phenylalaninol as a precursor for constructing highly selective asymmetric organocatalysts or phosphine ligands used in pure enantioselective transformations. By controlling input ratio and post-coupling purification, catalyst production lines achieve strict reproducibility and performance validation required for batch catalysis in fine chemical plants and contract manufacturing organizations.

Industry compliance standards

• ISO 9001:2015
• Responsible Care® Management System (RCMS)
• REACH chemical safety requirements for catalyst manufacturing
• Internal quality protocols for catalytic intermediates

Typical usage ratio

• Ranges from 7–28 wt% as initial molar input; tuned according to ligand scaffold design and desired chiral center density

Downstream process integration

• Entry stage: coupled to phosphine or pyridine cores during ligand synthesis
• Functional groups modified for solubility or metal-binding enhancement
• Boc group selectively removed for further derivatization or immobilization
• Final purification by column chromatography or crystallization before use in industrial reactors

Final product types

• Chiral ligands for asymmetric hydrogenation or cross-coupling
• Organocatalysts for enantioselective synthesis
• Preparative chromatography stationary phases
• Catalyst kits for pharmaceutical or fine chemical synthesis

4. Stereochemical Modifier in Agrochemical Intermediate Synthesis

Industrial agrochemical manufacturers apply this compound to create chiral centers in precursor molecules for selective herbicide and insecticide development. Batch processing incorporates the material at a critical intermediate step, establishing the required three-dimensional structure while ensuring compliance with regional pesticide and chemical manufacturing standards. Downstream synthesis uses enantiopure intermediates to optimize biological activity and reduce environmental persistence.

Industry compliance standards

• OECD Guidelines for the Testing of Chemicals
• EU Regulation (EC) No 1107/2009 for Plant Protection Products
• China GB/T 20782-2006 Standard for Pesticide Intermediates
• ISO 9001:2015 for quality management in chemical manufacturing

Typical usage ratio

• 5–22 mol% relative to chiral agrochemical core; ratio varies by target molecular structure and route selectivity

Downstream process integration

• Introduced at stereocenter-defining stage in multi-step reaction sequences
• Boc group cleaved prior to further functionalization or halogenation
• Intermediate tracked by NMR and GC during pilot runs
• Final product purified by liquid-liquid extraction or crystallization

Final product types

• Active intermediates for chiral herbicide and insecticide synthesis
• Key precursors for selective fungicides
• Chiral performance enhancers in specialty agricultural formulations
• Analytical intermediates for residue monitoring